StockNow
Log in
Other

Novo Nordisk (NOVOB DC) says it asked court to preliminary halt Eli Lily's (LLY) misleading GLP-1 advertising campaigns while Novo Nordisk's lawsuit proceeds

StockNow breaking-news AI analysis

Novo Nordisk is suing Eli Lilly for deceptive GLP-1 advertising, claiming Lilly uses outdated clinical data to falsely imply its treatments are more effective than Novo's latest high-dosage products.

2 stocks

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

Gulf official tells CNN “50:50” chance US and Iran could reach deal by Friday, CNN reports; Iranian delegation does not include IRGC, which would need to sign off on details of provisional agreement

Geopolitics

The draft agreed to by Iranian and Omani negotiators awaits final approval from Iran’s supreme leader, two regional officials told The Associated Press on Wednesday

Geopolitics

Only 'one or two issues' remain unresolved in Iran-Oman talks, a senior diplomatic source tells Al Jazeera